| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 960 | 2012 |
| Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients M Nucci, KA Marr, F Queiroz-Telles, CA Martins, P Trabasso, S Costa, ... Clinical Infectious Diseases 38 (9), 1237-1242, 2004 | 376 | 2004 |
| Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection M Nucci, EJ Anaissie, F Queiroz‐Telles, CA Martins, P Trabasso, C Solza, ... Cancer 98 (2), 315-319, 2003 | 358 | 2003 |
| Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ... The Lancet 397 (10292), 2361-2371, 2021 | 283 | 2021 |
| Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ... The Lancet 393 (10168), 253-264, 2019 | 248 | 2019 |
| Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients AL Oliveira, M De Souza, VMH Carvalho-Dias, MA Ruiz, L Silla, ... Bone marrow transplantation 39 (12), 775-781, 2007 | 237 | 2007 |
| Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group P Moreau, SK Kumar, J San Miguel, F Davies, E Zamagni, N Bahlis, ... The Lancet Oncology 22 (3), e105-e118, 2021 | 212 | 2021 |
| Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria A Maiolino, I Biasoli, J Lima, AC Portugal, W Pulcheri, M Nucci Bone marrow transplantation 31 (5), 393-397, 2003 | 202 | 2003 |
| Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry RJP de Magalhães, MB Vidriales, B Paiva, C Fernandez-Gimenez, ... Haematologica 98 (1), 79, 2013 | 175 | 2013 |
| Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection LMB da Fonseca, B Gutfilen, PHR de Castro, V Battistella, ... Experimental neurology 221 (1), 122-128, 2010 | 172 | 2010 |
| A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory … RZ Orlowski, L Gercheva, C Williams, H Sutherland, T Robak, T Masszi, ... American journal of hematology 90 (1), 42-49, 2015 | 157 | 2015 |
| High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program JR Mikhael, AR Belch, HM Prince, MN Lucio, A Maiolino, A Corso, ... British journal of haematology 144 (2), 169-175, 2009 | 140 | 2009 |
| Salvage second hematopoietic cell transplantation in myeloma LC Michaelis, A Saad, X Zhong, J Le-Rademacher, CO Freytes, DI Marks, ... Biology of Blood and Marrow Transplantation 19 (5), 760-766, 2013 | 123 | 2013 |
| Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients PH Rosado-de-Castro, FR Schmidt, V Battistella, SA Lopes de Souza, ... Regenerative medicine 8 (2), 145-155, 2013 | 123 | 2013 |
| Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation SC Maradei, A Maiolino, AM de Azevedo, M Colares, LF Bouzas, M Nucci Blood, The Journal of the American Society of Hematology 114 (6), 1270-1275, 2009 | 117 | 2009 |
| Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis S Kumar, MJ Zhang, P Li, A Dispenzieri, GA Milone, S Lonial, A Krishnan, ... Blood, The Journal of the American Society of Hematology 118 (7), 1979-1988, 2011 | 95 | 2011 |
| International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials LJ Costa, BA Derman, S Bal, S Sidana, S Chhabra, R Silbermann, JC Ye, ... Leukemia 35 (1), 18-30, 2021 | 94 | 2021 |
| Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy L Sanoja-Flores, J Flores-Montero, N Puig, T Contreras-Sanfeliciano, ... Blood, The Journal of the American Society of Hematology 134 (24), 2218-2222, 2019 | 90 | 2019 |
| Older patients with myeloma derive similar benefit from autologous transplantation M Sharma, MJ Zhang, X Zhong, MH Abidi, G Akpek, U Bacher, ... Biology of Blood and Marrow Transplantation 20 (11), 1796-1803, 2014 | 88 | 2014 |
| Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study BG Couto, RCS Goldenberg, LMB da Fonseca, J Thomas, B Gutfilen, ... Liver International 31 (3), 391-400, 2011 | 84 | 2011 |
Marcio NucciFederal University of Rio de Janeiro在 hucff.ufrj.br 的电子邮件经过验证
